Adagio Medical Holdings (ADGM) Preferred Stock Liabilities (2023 - 2024)
Adagio Medical Holdings (ADGM) reported Preferred Stock Liabilities of $91.5 million for Q4 2024, little changed on a YoY basis from $91.5 million in Q1 2024, and up 5.4% sequentially from $86.8 million in Q2 2024.
Adagio Medical Holdings (ADGM) Preferred Stock Liabilities (2023 - 2024) Analysis & Trends
Adagio Medical Holdings (ADGM) has 2 years of Preferred Stock Liabilities data on file, last reported at $91.5 million in Q4 2024.
- For the quarter ending Q4 2024, Preferred Stock Liabilities changed 0.0% year-over-year to $91.5 million; the trailing twelve-month figure through Dec 2024 stood at $91.5 million (changed 0.0% YoY), and the FY2024 full-year result was $91.5 million, changed 0.0% from the prior year.
- Preferred Stock Liabilities advanced to $91.5 million in Q4 2024, from $86.8 million in the prior quarter.
- In the past five years, Preferred Stock Liabilities ranged from a high of $91.5 million in Q3 2023 to a low of $86.8 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Adagio Medical Holdings | 21.49 Mn | 21.49 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 91.47 Mn |
| Jun 30, 2024 | 86.78 Mn |
| Mar 31, 2024 | 91.47 Mn |
| Dec 31, 2023 | 91.47 Mn |
| Sep 30, 2023 | 91.47 Mn |